Literature DB >> 35724342

Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?

Adi Kartolo1, Ian F Tannock2, Francisco E Vera Badillo1.   

Abstract

Entities:  

Year:  2022        PMID: 35724342     DOI: 10.1200/JCO.22.00705

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Metastatic prostate cancer gets into the biomarker era.

Authors:  Francisco E Vera Badillo
Journal:  Can Urol Assoc J       Date:  2022-10       Impact factor: 2.052

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.